Molecular Grading of Urothelial Cell Carcinoma With Fibroblast Growth Factor Receptor 3 and MIB-1 is Superior to Pathologic Grade for the Prediction of Clinical OutcomeBas W.G. van Rhijn, Ellen C. Zwarthoff, André N. Vis et al.|Journal of Clinical Oncology|2003Cited by 321
<b> <i>FGFR3</i> </b> and <b> <i>P53</i> </b> Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell CarcinomaBas W.G. van Rhijn, Ellen C. Zwarthoff, André N. Vis et al.|Cancer Research|2004Cited by 223
Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder CancerBas W.G. van Rhijn, Theodorus van der Kwast, Tahlita C.M. Zuiverloon et al.|European Urology|2010Cited by 193
Frequent <i>FGFR3</i> mutations in urothelial papillomaBas W.G. van Rhijn, Theodorus van der Kwast, Rodolfo Montironi et al.|The Journal of Pathology|2002Cited by 189
Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classificationsBas W.G. van Rhijn, Theodorus van der Kwast, Mireía Musquera et al.|Modern Pathology|2014Cited by 47